Home/ Stocks/ PYXS

Pyxis Oncology, Inc. Common Stock

PYXS XNAS

$1.36 -0.06 (-4.23%) ▼ 15-min delayed

Open

$1.44

High

$1.47

Low

$1.35

Volume

550.4K

Market Cap

$89.22M

About Pyxis Oncology, Inc. Common Stock

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 44 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-22,003,000	$-0.35
Q2 2025	$2.82M	$-18,354,000	$-0.30
Q1 2025	$0	$-21,158,000	$-0.35
FY 2024	$16.15M	$-77,331,000	$-1.32

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026

Calendar →

Related Market News

No specific coverage for PYXS yet. Check out our latest market news or earnings calendar.

Get PYXS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Pyxis Oncology, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.